Canada

Thumbnail for Entos to build US$137.2M R&D and manufacturing hub in Edmonton

14 March 2025

Entos to build US$137.2M R&D and manufacturing hub in Edmonton

Thumbnail for AstraZeneca invests US$570M in Canada, creating 700 jobs

24 January 2025

AstraZeneca invests US$570M in Canada, creating 700 jobs

Thumbnail for Health Canada approves FRUZAQLA for metastatic colorectal cancer treatment

22 January 2025

Health Canada approves FRUZAQLA for metastatic colorectal cancer treatment

Thumbnail for Neuralink begins clinical trial recruitment with Health Canada approval

22 November 2024

Neuralink begins clinical trial recruitment with Health Canada approval

Thumbnail for NanoVation secures funding, expands board

21 November 2024

NanoVation secures funding, expands board

Thumbnail for Moderna’s RSV vaccine gets approval in Canada

12 November 2024

Moderna’s RSV vaccine gets approval in Canada

Thumbnail for Health Canada approves DAYBUE for Rett Syndrome

18 October 2024

Health Canada approves DAYBUE for Rett Syndrome

Thumbnail for Health Canada approves Tagrisso combination for NSCLC patients

18 July 2024

Health Canada approves Tagrisso combination for NSCLC patients

Thumbnail for Vasomune’s AV-001 granted FDA fast-track designation for ARDS treatment

29 May 2024

Vasomune’s AV-001 granted FDA fast-track designation for ARDS treatment

Thumbnail for Biosimilar eye drug Yesafili gets green light for Canadian market entry in 2025

6 March 2024

Biosimilar eye drug Yesafili gets green light for Canadian market entry in 2025